[Synthetic progestins in combined treatment of cancer of the uterine body].
The effect of 17-hydroxyprogesterone-capronate therapy on primary tumor in 102 patients with cancer of the uterine body in 1-11 stage was studied. A more pronounced therapeutic effect of the hormone therapy was noted in patients with a high degree of differentiation and less tumor mass.